Peptide record

TPDB45137

Antiviral standard
31 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB45137
Antiviral
Anti-infective peptides
AVPpred-BWR
standard
No
A 31-aa standard-residue antiviral peptide sequence curated from AVPpred-BWR, with an available 3D structural model.
Sequence
YGGIEKKIEAIEKKIEAIEKKIEAIEKKIEA
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C161H277N39O49
RNDCQHLMFPSTWV
EIK
3543.20
7.21
8
8
13
+0
1.63
-0.584
113.55
Mammalian: 2.8 hour Yeast: 10 min E.coli: 2 min
1490
0.42
1
Residue Composition
number
4
A
0
R
0
N
0
D
0
C
8
E
0
Q
2
G
0
H
8
I
0
L
8
K
0
M
0
F
0
P
0
S
0
T
0
W
1
Y
0
V
Amino Acid Distribution
A: 4 R: 0 N: 0 D: 0 C: 0 E: 8 Q: 0 G: 2 H: 0 I: 8 L: 0 K: 8 M: 0 F: 0 P: 0 S: 0 T: 0 W: 0 Y: 1 V: 0
Chemical Descriptors
31 reviewed residue count
C161H277N39O49 sequence-only estimate (linear, free termini)
3543.20 sequence-only estimate (linear, free termini)
7.21 sequence-only estimate (linear, free termini)
+0 sequence-only estimate (linear, free termini)
1.63 sequence-only estimate (linear, free termini)
-0.584 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

NA